Navigation Links
Alzheimer's disease: The first prevention study of its kind
Date:9/21/2011

This press release is available in French.

Researchers at the Douglas Mental Health University Institute, in Montreal, Quebec, are about to launch the first epidemiological study on the prevention of Alzheimer's disease.

"As far as we know, this is the first study of its kind to be carried out anywhere in the world," states John Breitner, the study's lead investigator and Director of the new Centre for Studies on Prevention of Alzheimer's Disease (StoP-Alzheimer). Dr John Breitner and Dr Judes Poirier, the Centre's Associate Director, will be recruiting 250 healthy adults aged 60 or over, who have (or had) a parent, brother or sister with Alzheimer's disease, in order to learn which methods are most effective at preventing this neurodegenerative condition.

Using a combined diagnostic approach of brain imaging and cerebrospinal fluid analysis, the researchers will observe their subjects' biomarkers for a period of ten years to find out which preventative agents can stop the disease from developing, long before symptoms appear. The preventative agents involvedfive in allhave already shown promising results in previous studies. They are anti-inflammatory medications, insulin, physical activity, the Mediterranean diet, and drugs stimulating the production of a protein connected to the apoE gene.

The future of Alzheimer's research

For more than a decade, research into the treatment of Alzheimer's disease, whether pharmacological or other, has not produced the desired results. To date, only some symptoms relating to cognitive decline or memory loss can be treated. Observations by scientists suggest that the focus should shift to prevention and that money should be invested in major studies into this aspect of the disease. "Alzheimer's is a public health crisis that could take on catastrophic proportions in the coming years. It is i
'/>"/>

Contact: Marie france Coutu
marie-france.coutu@douglas.mcgill.ca
514-835-3236
Douglas Mental Health University Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Thyroid Disease: The Hidden Epidemic
2. Understanding causes of cancer and chronic disease: The Canadian Partnership for Tomorrow Project
3. Patients at high risk of recurrences of heart disease: Breakthrough in prevention
4. Crohn's & Colitis Foundation National Event Helping Women Manage Inflammatory Bowel Disease: Two Women Physician Experts and Researchers in IBD on Interactive Webcast/Teleconference
5. HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study
6. Chronic Lyme disease: How often is it diagnosed and treated?
7. Parkinsons disease: Excess of special protein identified as key to symptoms and possible new target for treatment with widely used anti-cancer drug imatinib
8. Air Pollution Ups Risk of Chronic Lung Disease: Study
9. Shorter Sleep in Men Ups Risk of Heart Disease: Study
10. Destined for disease: Breast cancer mutation regulates cell fate
11. DMP for coronary heart disease: Current guidelines indicate some need for revision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... that protects people from crime and other hostile situations. , "The Security Services ... Creative Director of World Patent Marketing. "The industry is growing at a healthy ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please join the world renowned ... which was established by the Foundation in 2007 with the help of Massachusetts ... more research remains our top priority,” commented Christine Buckley, Executive Director of the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Mobile working is increasingly more important, ... seems that everywhere new mobile apps are being launched, and mobile device usage as ... regular part of their work and personal lives. What's more people are expecting mobile ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
Breaking Medicine News(10 mins):Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... Inc. (NYSE: FRX ) today announced that ... the Company,s supplemental New Drug Application (sNDA) for Lexapro ... Major Depressive Disorder (MDD) in adolescents, 12 - 17 ... to be approved for the treatment of MDD in ...
... Finding could lead to new treatments for cognitive ... News) -- The human brain functions on "the ... order and randomness, according to U.K.-based researchers who ... cognitive performance and psychiatric disorders. , The ...
... 20 CANTEL MEDICAL CORP. (NYSE: ... of the Company, to President and Chief Executive Officer. ... of Directors. Since joining Cantel in September 2004, Mr. Krakauer ... 2008 as President. The Board concurrently appointed Seth R. Segel, ...
... the Migraine Research Foundation (MRF) announced a new initiative ... migraine called FOR OUR CHILDREN. The new program ... understanding of migraine and its causes and treatments in ... , Migraine is very common in children - ...
... SEGUNDO, Calif., March 20 A former astronaut and ... a director of business development for Wyle,s Integrated Science ... Parazynski joins Wyle to assist in the company,s continued ... health and performance services to the Federal Government. He ...
... obscure clinical manifestation of severe vomiting sickness due to ... his colleagues at the Creighton University of Omaha, NE, ... of Gastroenterology . , Recent research into the neurobiology ... receptor types including two specific types that mediate neuropsychiatric ...
Cached Medicine News:Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 2Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 3Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 5Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 6Health News:Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments 2Health News:New initiative to support pediatric migraine research is announced 2Health News:Veteran Astronaut Joins Wyle Business Development Staff in Houston 2
(Date:9/1/2015)... SALT LAKE CITY , Sept. 1, 2015 ... announced that it will present at the First ... Hotel in New York City.  Kelvyn H. ... to present to leading institutional investment representatives on ... The Ladenburg Thalmann Conference will showcase ...
(Date:9/1/2015)... -- Dr. Cindy Orser , the Chief Science Officer ... of DigiPath, Inc. (OTCQB: DIGP), was recently interviewed ... consistency in today,s medical cannabis testing industry. In her ... she explained that the state-to-state variations in cannabis laws ... makes standardization impossible. Dr. Orser is ...
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
Breaking Medicine Technology:DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3
... Calif. , Feb. 15 Accuray Incorporated (Nasdaq: ... today that Mount Vernon Cancer Centre in the United Kingdom ... acquire a CyberKnife® Robotic Radiosurgery System. , The NHS has grown ... was born just over 60 years ago out of a long-held ...
... , RESEARCH TRIANGLE PARK, N.C. , ... CRO, has formed an exclusive team of India ,s ...  The team consists of the best Minimal Access Surgeons in ...   , Having already conducted multiple Minimally Invasive Device Trials ...
Cached Medicine Technology:Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System 2Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System 3Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System 4Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System 5Max Neeman International Expands Specialized Surgical Team for Clinical Trials 2
... the first commercially available real-time detection ... use. , ,The kit can detect ... genotypes of HPV providing the sensitivity ... simplifying the process by using a ...
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
Medicine Products: